Global glaucoma treatment drugs market forecast to 2020

Global Glaucoma Treatment Drugs Market Forecast to 2020 : Ken Research • Ken Research announced its latest publication on “ Global Glaucoma Treatment Drugs Market Outlook to 2020 – New Product Launches Expected to Boost Market ” provides a comprehensive analysis of the glaucoma treatment drugs market. The report includes the market share contributed by the sales of generic and patented drugs globally for treatment of glaucoma.

What Is The Potential Of Global Glaucoma Treatment Drugs Market? • Glaucoma is defined as a group of disorders of optic nerve, which carries information from eye to the brain. Major symptom of glaucoma is ocular hypertension, which is associated with higherthan-normal-pressure inside the eye. Moreover, sometimes glaucoma also affects eyes with normal eye pressure. If untreated or uncontrolled, glaucoma causes peripheral vision loss and eventually results in blindness. Glaucoma being the second common cause of blindness globally has emerged as a worldwide problem. The prevalence of glaucoma globally among aged population was ~% in 2013. There were around ~ million people who were affected with glaucoma worldwide in year 2010, which increased to ~ million in 2013 and number is expected to increase to ~ million by 2020.

•

The statistics clearly advocates the high demand for glaucoma treatment drugs across the globe. It has been estimated that glaucoma treatment drugs generated USD ~ million of revenue in 2010. However, the revenue declined at a high rate till 2013, owing to the expiry of major patented drugs including ~ and ~. It was observed that market exhibited the decline at a rate of ~% from 2011to 2012 on account of declining sales of ~. Although as a result of increasing prevalence of glaucoma, market experienced steady growth afterwards and the market was valued at USD ~ million in 2015.

Aging population and rising awareness in. the emerging economies owing to the efforts of the government and NGOs were the major reasons which assisted the market in its growth during this period.

Figure: Global Glaucoma Treatment Drugs Market On The Basis Of Revenue In USD Million, 2010 - 2015

USD Million

6.00 5.00 4.00 3.00 2.00 1.00 0.00 2010

2011

2012

2013

2014

2015

Which Drug Class Is Generating Maximum Revenue For Glaucoma Treatment Drugs Market?

• Prostaglandin analogs dominated the glaucoma treatment drugs market with revenue share of ~% in 2015. The drugs belonging to prostaglandin analogs work by increasing the outflow of intraocular fluid from the eye. These drugs are usually taken as eye drops and preferred for people with open angle glaucoma. Presence of two patented drugs in this drug class is one of the major factors which are responsible for dominance of prostaglandin analogs ~, ~, and ~ are major patented drugs generating revenue for the segment.

Additionally, ~ which is an off-patented drug also generated USD ~ million of the revenue in year 2015, contributing a high share in the total segment revenue. Beta blockers followed prostaglandin analogs with revenue share of ~% in 2015.This drug class works by decreasing the production of intraocular fluid. These drugs are majorly available in generic form and are relatively inexpensive. This feature of beta blockers drug class makes it one of the preferred choices of drug in the emerging economies of Asia Pacific and Latin America region.

Which Geographical Region Dominated The Global Glaucoma Treatment Drugs Market?

• North America dominated the market with revenue share of ~% in 2015. High prevalence of glaucoma, high awareness among people and economic stability to undergo expensive treatment options are the major factors which have driven the glaucoma treatment drugs market in North America. Approximately ~ million people in the US were affected from glaucoma in 2015. Moreover, it has been observed that ~ people in the US were blind due to glaucoma, accounting for ~% of all the blindness cases in 2015.African Americans residing in the region are ~ times more likely to develop glaucoma than any other descent globally. Europe followed North America with revenue share of ~% in 2015. Nominal approval regulations and easy availability of the drugs in fewer prices in the region owing to the reimbursement from the government are the major factors which have helped the market players to generate high revenue in the nation. Aging population is other major reason which has resulted in high glaucoma prevalence in the region, resulting in demand for treatment drugs.

What Is The Scenario Of Asia Pacific Region In Context To Glaucoma Treatment Drugs Market? • The snapshot on Asia Pacific glaucoma treatment drugs market included in study discusses about three major markets in the region including India, China, and Japan. India though generated very low revenue of USD ~ million in 2015 is expected to grow at a high pace during the forecast period. High prevalence of glaucoma in the country coupled with rising awareness is expected to fuel the glaucoma treatment drugs market in India.

Additionally, absence of any patented drug and use of only generic products has also resulted in low revenue contribution from India towards global market. Among generic drug manufacturers, ~ dominated the market with revenue share of ~ % in 2015 followed by ~, which contributed ~% in the total revenue. Carbonic Anhydrase inhibitors are estimated to generate maximum revenue by drug class contributing ~% in the overall revenue in year 2015 in India.

How Are Generic Glaucoma Drugs Different From Branded Glaucoma Drugs?

• Glaucoma being a highly prevalent disease demands for effective and affordable treatment options. The launch of generic drugs in the market during the historical period, especially of Xalatan has resulted in decline in revenue share of patented drugs in the market from ~% in 2010 to ~% in 2015. Low cost of generic drugs is the major factor which has resulted in high adoption of generic drugs in the market. It has been observed that branded drugs cost approximately five times that of generic drugs

How Venturing Of Small Players Is Going To Impact Global Glaucoma Treatment Drugs Market?

• Glaucoma treatment drugs market is witnessing the entry of many small players into the market especially in research and development activities. These new entrants are conducting massive clinical trials for glaucoma treatment and their drugs are expected to revolutionize the market. Nearly ~ drugs by small companies are observed to be in clinical phase III trial and are expected to launch during the forecast period. The major among them include ~ and ~ by Aerie Pharmaceutical and ~ by Inotek Pharmaceutical Corporation. Moreover, the drugs by ~ belong to new drug class called ROCK Inhibitors, which is completely new mechanism of treatment for glaucoma.

What Would Be The Result Of New Product Launches On Global Glaucoma Treatment Drugs Market During The Forecast Period?

• Glaucoma treatment drugs are expected to witness growth at a rapid pace. The market is expected to grow at a CAGR of ~% from 2016 to 2020 recording the market value at USD ~ million in 2016 and USD ~ million in 2020. Launch of ~, ~, ~, and ~ are expected to generate good amount of revenue during the forecast period However, the market would be restrained a bit by the patent expiry of ~ and ~. The expected launch of ~ by Bausch & Lomb Incorporated in 2016 is expected to revolutionize the market, as the drug is expected to generate sales of nearly ~billion in year 2017.It is anticipated that the drug would be used as a first-line therapy for the treatment of glaucoma. Strong efficacy and simplified therapeutic regiment agent presence in the drug would increase the use of drug.

Key Factors Considered In The Report • Comprehensive analysis of the Global glaucoma treatment drugs market and its segments • Snapshot on North America Glaucoma Treatment Drugs Market • Snapshot on Europe Glaucoma Treatment Drugs Market • Snapshot on Asia Pacific Glaucoma Treatment Drugs Market • Porter’s Five Forces Analysis for Global Glaucoma Treatment Drugs Market • Trends and Developments in Global Glaucoma Treatment Drugs Market • Snapshot on Patented Glaucoma Treatment Drugs Market • Generic Versus Branded Glaucoma Drugs • Pipeline Analysis of Global Glaucoma Treatment Drugs Market • Competitive Landscape and Detailed Company Profiles of the Major Market Players • Future Outlook and Projections of Global Glaucoma Treatment Drugs Market • Analyst Recommendations • Macro-Economic Factors Impacting the Global Glaucoma Treatment Drugs Market

•

Source : https://www.kenresearch.com/healthcare/pharmaceuticals/globalglaucoma-treatment-drugs-market-statistics/47381-91.html

•

Contact: Ken Research Ankur Gupta, Head Marketing & Communications Ankur@kenresearch.com +91-9015378249 Website : www.kenresearch.com

•

Thank you